Physician profile
Jane Woo
NPI 1326208158
$618.50
in general payments reported to CMS, 2019-2025
12 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $120 · 2022: $176 · 2023: $107 · 2024: $101 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $322.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $135.49 | 2022-2025 | Lynparza, Keytruda |
| Abiomed | $127.34 | 2022 | |
| Bard Peripheral Vascular, INC. | $63.59 | 2021 | |
| Molli Surgical (US) INC | $58.77 | 2023 | |
| Tactile Systems Technology INC | $56.69 | 2021 | |
| Hologic Sales and Service, LLC | $43.01 | 2023-2024 | Trident Specimen Radiography System, Localizer, Trunode |
| Becton, Dickinson and Company | $35.85 | 2025 | Arista |
| Innovation Technologies INC | $24.72 | 2025 | Irrisept |
| Baxter Healthcare | $23.06 | 2024 | Tisseel |
| Stryker Corporation | $22.26 | 2025 | Molli, Spy-Phi System |
| Dilon Technologies, INC. | $15.89 | 2022 | |
| Hologic INC | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Woo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.